JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA

This adverse event was reported 51 times

These drugs are most commonly taken by patients reporting JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA:

# Drug Count
0 FLUDARABINE PHOSPHATE 20
1 METHOTREXATE SODIUM 13
2 METHOTREXATE 12
3 CYTARABINE 11
4 CYCLOPHOSPHAMIDE 10
5 CYCLOPHOSPHAMIDE FOR INJECTION 10
6 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 10
7 TREOSULFAN 10
8 AZACITIDINE 9
9 AZACITIDINE FOR 9
See all common drugs associated with JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA

JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TREOSULFAN 10 0.0036
1 PURIXAN 1 0.0013
2 DEXRAZOXANE FOR INJECTION 1 0.0011
3 CASPOFUNGIN ACETATE 1 0.0006
4 DEFIBROTIDE SODIUM 2 0.0006
5 FLUDARABINE PHOSPHATE 20 0.0005
6 THIOGUANINE 1 0.0005
7 MERCAPTOPURINE 6 0.0003
8 BUSULFAN 5 0.0003
9 AZACITIDINE 9 0.0003
See all drugs enriched for association with JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA